<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5090704 Figure_1-B</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Confocal fluorescence microscopy of 293T cells transfected with 0.5 &#956;g pQCXIP encoding IFITM3 variants containing N-terminal FLAG (pQCXIP-FLAG-IFITM3) and immunostained with anti-FLAG M2 antibody. Scale bar, 5 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_1-C</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Flow cytometry analysis of transfected cells in (B) immunostained with anti-FLAG M2 antibody. Corresponding mean flourescence intensity values are shown.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_1-D</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) SDS-PAGE of cell lysates derived from 293T cells transfected in (B) followed by immunoblotting with anti-FLAG M2 and anti-actin antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_1-E</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) SDS-PAGE of Opti-prep purified supernatants (25 ng p24 equivalent) derived from 293T cells transfected with pQCXIP-FLAG-IFITM3 variants, HIV-1 pNL4-3, and Vpr-Blam plasmid followed by immunoblotting with anti-FLAG M2 and anti-p24 Gag (183-H12-5C).</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_1-F-G</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 1-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Opti-prep purified supernatants from (E) were incubated with SupT1 target cells for 4 hours and virus-cell fusion was scored by flow cytometry. Mean + SD of 5-10 experiments (each performed with virus produced from an independent transfection) is shown. (G) Virus used in (E) were used to infect SupT1 cells and productive infection was scored at 48-60 hours by immunostaining with the KC57 antibody and flow cytometry. Expression of pCMV-MxA served as a negative control. The mean + SD of 5-10 experiments is shown.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_1-H</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 1-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Confocal fluorescence microscopy of 293T cells transfected with 0.5 &#956;g pQCXIP-FLAG-IFITM3 variants and immunostained with anti-FLAG M2 antibody</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_1-I</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 1-I</infon>
    <infon key="sourcedata_figure_dir">Figure_1-I</infon>
    <passage>
      <offset>0</offset>
      <text>(I) SDS-PAGE of cell lysates derived from 293T cells transfected in (H) followed by immunoblotting with anti-FLAG M2 and anti-actin antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_1-J</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 1-J</infon>
    <infon key="sourcedata_figure_dir">Figure_1-J</infon>
    <passage>
      <offset>0</offset>
      <text>(J) SDS-PAGE of Opti-prep purified supernatants (25 ng p24 equivalent) derived from 293T cells transfected with pQCXIP-FLAG-IFITM3 constructs, HIV-1 pNL4-3, and Vpr-Blam plasmid followed by immunoblotting with anti-FLAG M2 and anti-p24 Gag. Scale bar, 5 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_1-K</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 1-K</infon>
    <infon key="sourcedata_figure_dir">Figure_1-K</infon>
    <passage>
      <offset>0</offset>
      <text>(K) Opti-prep purified supernatants from (J) were incubated with SupT1 target cells for 4 hours and virus-cell fusion was scored by flow cytometry. The mean + SD of 3 experiments is shown.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_2-A</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Confocal fluorescent microscopy of SupT1 T cells transduced with Tet-inducible pQCXIP-FLAG-IFITM3 or pQCXIP-FLAG-IFITM3 &#916;1-21 (Tet-ON) immunostained with anti-FLAG M2 antibody following overnight treatment with 500 ng/mL doxycycline. Scale bar, 10 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_2-B</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Tet-ON SupT1 cell lines were treated or not with 500 ng/mL doxycycline overnight and induction of IFITM3 protein was assessed anti-FLAG M2 immunostaining and flow cytometry.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_2-C</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Tet-ON SupT1 cell lines were productively infected with NL4-3 VSV-G and then treated with 500 ng/mL doxycycline overnight to produce virus from IFITM3- and IFITM3+ cells. 25 ng p24 equivalents of purified were used to infect fresh Tet-ON SupT1 cells cell targets, which were previously treated with 500 ng/mL doxycycline or not. Infection was scored at 72h post-infection by immunostaining with KC57 and flow cytometry. Mean + SD of 3 experiments are shown.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_2-D</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) 25 ng p24 equivalents of virus used in (C) was subjected to SDS-PAGE. Immunoblotting was performed using the anti-FLAG M2, anti-p24 Gag, and anti-gp120 Env (NIH #288) antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_2-E</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) 293T cells were transfected with the indicated amount of pQCXIP-FLAG-IFITM3 or pQCXIP-FLAG-&#916;1-21 or pCMV-MxA and 1.0 &#956;g of HIV-1 pNL4-3. SDS-PAGE was performed on whole cell lysates followed by immunoblotting with anti-FLAG M2, anti-p24 Gag, anti-Env gp120 (NIH #288), and anti-tubulin antibodies. Western blot images are representative of 3 independent experiments. Unpaired t-test, *p&lt;0.05, &#9839;p=0.12, non statistically significant. Comparisons were made between the condition indicated and the correponding condition in Tet-ON IFITM3 cells.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_5-A</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Confocal fluorescence microscopy of 293T cells transfected with 0.5 &#956;g of pQCXIP-FLAG-Human IFITM3 mutated at indicated residues and immunostained with anti-FLAG M2 antibody. Scale bars, 5 &#956;m. The P17L, P18H, &#916;22-24, P18L/L23P and P18H/&#916;19-23 mutations were introduced into the human IFITM3 background.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_5-B</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) SDS-PAGE of FLAG-immunoprecipitated fractions from 293T cells following transfection of 0.5 &#956;g of pQCXIP-FLAG-IFITM3 variants and 0.5 &#956;g of pCI-HA-NEDD4 or pCI-HA-NEDD4 C867A. Immunoblotting was performed with anti-FLAG M2, anti-IFITM3 (Abcam, EPR5242), and an anti-ubiquitin antibody (Enzo Life Sciences, recognizing K29-, K48-, and K63-linked mono- and polyubiquitinylated proteins). 'L' indicates the presence of light chain antibody derived from the FLAG antibody-coupled beads used for immunoprecipitation. *, **, and *** indicate mono-, di-, and tri-ubiquitinated forms of IFITM3.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_5-C</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) SDS-PAGE of whole cell lysate input fractions from 293T cells used in (B). Immunoblotting was performed with anti-FLAG M2, anti-NEDD4, and anti-actin.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_5-D</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) 293T cells were transfected with 1.0 &#956;g of pNL4-3 and 0.5 &#956;g of pQCXIP-FLAG-IFITM3 variants. Virus-containing supernatants were harvested and 10 ng p24 equivalents were used to reinfect fresh SupT1 T cells. Productive infection was scored by immunostaining with the KC57 antibody and flow cytometry at 48 hours post-infection. The means + SD of 3 experiments are shown.</text>
    </passage>
  </document>
  <document>
    <id>5090704 Figure_5-E-F</id>
    <infon key="sourcedata_document">2257</infon>
    <infon key="doi">10.15252/embr.201642771</infon>
    <infon key="pmc_id">5090704</infon>
    <infon key="figure">Figure 5-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E) 2.0 x 10&#710;5 cells were seeded and challenged with 10 ng of HIV-1NL4-3 in the presence of 2 &#956;g/mL DEAE-Dextran. Productive infection was scored by immunostaining with KC57 and flow cytometry at 48 hours post-infection. The 'Colobus native' sequence represents the full IFITM3 sequence identified in the colobus monkey. (F) As in (E), except cells were challenged with Influenza A virus H1N1 PR/8/34, (Charles River Laboratories), at a dose that resulted in &#732;50% infection of control (Empty) cells (equivalent to 103 TCID50 / 0.2 mL). Infection was scored by immunostaining with an anti-IAV NP antibody and flow cytometry at 18 hours post-infection. Results are presented in a logarithmic scale. Means + SD of 3-5 experiments are shown. Unpaired t-test, *p&lt;0.05, **p&lt;0.005.</text>
    </passage>
  </document>
</collection>
